{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:58:49Z","timestamp":1795096729890,"version":"4.10.2"},"reference-count":52,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pain"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pain is a common symptom of Parkinson's disease (PD). It occurs also as a prodromal sign of PD. It has not yet been described how the use of analgesics changes over time in persons with PD. We investigated the incidence of opioid use from 5\u2009years before to 5\u2009years after PD diagnosis and compared the incidence to a matched cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 15,763 people diagnosed with incident PD in 2001\u20132014 and 62,907 matched comparison persons without PD from the Finnish nationwide register\u2010based study on Parkinson's disease (FINPARK). Initiation rates of opioid use during the follow\u2010up were calculated in 6\u2010month time windows, and the difference between persons with and without PD was described using incidence rate ratios (IRRs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Opioid initiation was more common among persons with PD (37.0%) compared to people without PD (31.2%). The difference between the groups emerged 3\u2009years before the PD diagnosis IRR 1.33 (1.16\u20131.53), and remained until the end of the follow\u2010up. Mild opioids, such as tramadol and codeine, were the most commonly initiated opioids, and the largest difference in their use was observed 6\u2009months prior to the diagnosis date, while differences in strong opioids emerged after the PD diagnosis. Initiation rates increased over time and remained above those of the comparison group after the PD diagnosis for all opioid classes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings demonstrate the incidence of moderate\/severe pain in PD, which requires treatment with opioid\u2010class analgesics. Further studies are needed to understand the long\u2010term impact of opioid use in persons with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance Statement<\/jats:title>\n                    <jats:p>Initiation rate of opioids is increased in persons with Parkinson's disease already at premotor or early motor stage, before the diagnosis is confirmed. Shift towards stronger opioids is observed over the disease progress. Further studies are needed to investigate optimized pain management strategies in Parkinson's disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejp.70056","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T03:33:29Z","timestamp":1749440009000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence of Opioid Use Before and After Parkinson's Disease Diagnosis"],"prefix":"10.1002","volume":"29","author":[{"given":"Majd","family":"Al\u2010Sagheer","sequence":"first","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1863-3979","authenticated-orcid":false,"given":"Niina","family":"Karttunen","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0313-7080","authenticated-orcid":false,"given":"Anne","family":"Paakinaho","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-8360","authenticated-orcid":false,"given":"Marjaana","family":"Koponen","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"},{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences Monash University  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-7093","authenticated-orcid":false,"given":"Valtteri","family":"Kaasinen","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences University of Turku  Turku Finland"},{"name":"Neurocenter Turku University Hospital  Turku Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-455X","authenticated-orcid":false,"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-5045","authenticated-orcid":false,"given":"Miia","family":"Tiihonen","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-9268","authenticated-orcid":false,"given":"Anna\u2010Maija","family":"Tolppanen","sequence":"additional","affiliation":[{"name":"School of Pharmacy University of Eastern Finland  Kuopio Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000520574"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2008.04.026"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29878"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24054"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202069"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8426-y"},{"key":"e_1_2_8_8_1","article-title":"Opioids Compared to Placebo or Other Treatments for Chronic Low\u2010Back Pain","volume":"2013","author":"Chaparro L. E.","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkab095"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002968"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13323"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2008.2"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint12030014"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e31818af7ef"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00235-2"},{"key":"e_1_2_8_16_1","unstructured":"Finnish Medicines Agency Fimea and Social Insurance Institution.2020.\u201cFinnish Statistics on Medicines 2019.\u201d"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22716"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v5.i3.73"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2014.10.028"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-021-02145-6"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOT.0000000000001430"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.04.019"},{"key":"e_1_2_8_24_1","article-title":"Substance Use Disorders in Patients With Parkinson's Disease and Adverse Hospitalization Outcomes: A National Inpatient Study","volume":"13","author":"Kaur J.","year":"2021","journal-title":"Cureus"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3776"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.05.020"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac205"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00867-1"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002107"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22142"},{"key":"e_1_2_8_31_1","article-title":"Long\u2010Term Opioid Management for Chronic Noncancer Pain","volume":"2010","author":"Noble M.","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_8_32_1","first-page":"498","article-title":"Amfetamiinien Ja Opioidien ongelmak\u00e4yt\u00f6n Yleisyys Suomessa 2012 [the Prevalence of Amphetamine and Opioid Abuse in Finland in 2012]","volume":"5","author":"Ollgren J.","year":"2014","journal-title":"Yhteiskuntapolitiikka"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01002-7"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16122216"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"e_1_2_8_36_1","article-title":"The Risk Factors for the Wearing\u2010Off Phenomenon in Parkinson's Disease","volume":"12","author":"Raja K.","year":"2020","journal-title":"Cureus"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70287-X"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa249"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.12.099"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.12.098"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27602"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.0003"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-012-0005-2"},{"key":"e_1_2_8_44_1","unstructured":"Substance Abuse and Mental Health Services Administration.2013.\u201cResults From the 2012 National Survey on Drug Use and Health: Summary of National Findings. (Rockville MD: Substance Abuse and Mental Health Services Administration).\u201d"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2019.11.004"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00243-4"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2015.122"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136541"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/781479"},{"key":"e_1_2_8_50_1","volume-title":"Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents","author":"WHO","year":"2018"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.6.721"},{"key":"e_1_2_8_52_1","unstructured":"Working group set up by the Finnish Medical Society Duodecim The Finnish Society of Anaesthesiologists and the Finnish Association for General Practice.2017.Current Care Guidelines: Pain (Helsinki Finland: The Finnish Medical Society Duodecim)."},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2017.11.1146"}],"container-title":["European Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ejp.70056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T04:44:13Z","timestamp":1764477853000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ejp.70056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1002\/ejp.70056"],"URL":"https:\/\/doi.org\/10.1002\/ejp.70056","archive":["Portico"],"relation":{},"ISSN":["1090-3801","1532-2149"],"issn-type":[{"value":"1090-3801","type":"print"},{"value":"1532-2149","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"2025-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70056"}}